Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lenalidomide-I (Compound 72) is a derivative of the cereblon (CRBN) ligand, Lenalidomide, with affinity for E3 ubiquitin ligase. It facilitates the recruitment of CRBN protein. Lenalidomide-I can be utilized in PROTACs, such as the PROTAC BET degrader QCA570, by linking it to the targeted protein ligand through a linker.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | 5 days | Inquiry | |
100 mg | 5 days | Inquiry |
Description | Lenalidomide-I (Compound 72) is a derivative of the cereblon (CRBN) ligand, Lenalidomide, with affinity for E3 ubiquitin ligase. It facilitates the recruitment of CRBN protein. Lenalidomide-I can be utilized in PROTACs, such as the PROTAC BET degrader QCA570, by linking it to the targeted protein ligand through a linker. |
In vitro | Lenalidomide-I can be linked to a protein ligand via a linker to create PROTACs, which are agents that induce the ubiquitination-mediated degradation of proteins that promote cancer[1]. |
Molecular Weight | 370.14 |
Formula | C13H11IN2O3 |
CAS No. | 2207541-30-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lenalidomide-I 2207541-30-6 LenalidomideI Lenalidomide I inhibitor inhibit